These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3003730)

  • 1. [Worldwide experience with enalapril].
    Davies RO; Irvin JD; Kramsch DK; Walker JF; Moncloa F
    Presse Med; 1985 Dec; 14(44):2245-55. PubMed ID: 3003730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enalapril worldwide experience.
    Davies RO; Irvin JD; Kramsch DK; Walker JF; Moncloa F
    Am J Med; 1984 Aug; 77(2A):23-35. PubMed ID: 6089556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of enalapril in moderate to severe essential hypertension.
    Walker JF; Kulaga SF; Kramsch DM
    J Hypertens Suppl; 1984 Dec; 2(2):S107-11. PubMed ID: 6100871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with converting-enzyme inhibitors in hypertension.
    Weber MA
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):45-51. PubMed ID: 3037889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overall tolerance and safety of enalapril.
    McFate Smith W; Kulaga SF; Moncloa F; Pingeon R; Walker JF
    J Hypertens Suppl; 1984 Dec; 2(2):S113-7. PubMed ID: 6100872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.
    Todd PA; Heel RC
    Drugs; 1986 Mar; 31(3):198-248. PubMed ID: 3011386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance and safety of enalapril.
    McFate Smith W; Davies RO; Gabriel MA; Kramsch DM; Moncloa F; Rush JE; Walker JF
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):249S-253S, 255S. PubMed ID: 6099740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibitors: are they all alike?
    Case DB
    J Clin Hypertens; 1987 Sep; 3(3):243-56. PubMed ID: 2822859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of two angiotensin converting enzyme inhibitors in primary hypertension--a comparison of captopril and enalapril.
    Karlberg BE; Sjöstrand A; Ohman KP
    J Hypertens Suppl; 1986 Dec; 4(5):S432-4. PubMed ID: 3033182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enalapril versus captopril: a double-blind multicentre comparison in essential hypertension.
    Rumboldt Z; Marinković M; Drinovec J
    Int J Clin Pharmacol Res; 1988; 8(3):181-8. PubMed ID: 2841251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
    Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A parallel study of enalapril and captopril and 1 year of experience with enalapril treatment in moderate-to-severe essential hypertension.
    Thind GS; Johnson A; Bhatnagar D; Henkel TW
    Am Heart J; 1985 Apr; 109(4):852-8. PubMed ID: 2984913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal insufficiency during angiotensin-converting enzyme inhibitor therapy in hypertensive patients with no renal artery stenosis.
    Thind GS
    J Clin Hypertens; 1985 Dec; 1(4):337-43. PubMed ID: 3014079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of captopril and enalapril in patients with severe chronic heart failure.
    Packer M; Lee WH; Yushak M; Medina N
    N Engl J Med; 1986 Oct; 315(14):847-53. PubMed ID: 3018566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enalapril: a new angiotensin converting enzyme inhibitor.
    Cleary JD; Taylor JW
    Drug Intell Clin Pharm; 1986 Mar; 20(3):177-86. PubMed ID: 3007062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life and antihypertensive therapy in men. A comparison of captopril with enalapril. The Quality-of-Life Hypertension Study Group.
    Testa MA; Anderson RB; Nackley JF; Hollenberg NK
    N Engl J Med; 1993 Apr; 328(13):907-13. PubMed ID: 8446137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute antihypertensive synergism of angiotensin-converting enzyme inhibitors and diuretics.
    Chan PS; Ronsberg MA; Cervoni P
    Fed Proc; 1984 Apr; 43(5):1346-50. PubMed ID: 6200364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of angiotensin converting enzyme inhibitors in hypertension.
    Gavras I; Gavras H
    Am J Med; 1986 Oct; 81(4C):28-31. PubMed ID: 3022582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the efficacy of enalapril + hydrochlorothiazide and captopril + hydrochlorothiazide combinations in mild-to-moderate arterial hypertension by ambulatory measurement of blood pressure].
    Mayaudon H; Chanudet X; Janin G; Madonna O
    Ann Cardiol Angeiol (Paris); 1995 May; 44(5):235-41. PubMed ID: 7639505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.